期刊文献+

HPLC法测定血浆中头孢丙烯浓度及其人体药动学研究 被引量:5

Determination of Plasma Level of Cefprozil by HPLC and Its Pharmacokinetics in Human Body
原文传递
导出
摘要 目的:建立测定人血浆中头孢丙烯(CFPZ)浓度的高效液相色谱法,并应用于人体药动学研究。方法:10名男性健康受试者单次空腹口服CFPZ片500mg,采用高效液相色谱法测定CFPZ的血药浓度,色谱柱为KromasilKR100-5C18,流动相为0·01mol·L-1KH2PO4水溶液-乙腈(100:9·5),检测波长为254nm,柱温为室温,流速为1·0mL·min-1,进样量为20μL。结果:CFPZ血药浓度在0·25~15μg·mL-1范围内线性关系良好(r=0·9999),最低检测浓度为0·25μg·mL-1;低、中、高(0·25、0·5、2·5μg·mL-1)3种浓度(n=5)的日内RSD分别为4·8%、3·5%、1·3%,日间RSD分别为12·6%、6·7%、1·6%,相对回收率分别为97·7%、102·5%、103·6%,绝对回收率分别为88·5%、87·8%、85·3%。受试者单次空腹口服CFPZ片500mg后的Cmax为(8·66±1·57)mg·L-1,tmax为(1·85±0·8)h,t1/2为(1·4±0·18)h,AUC0~10为(28·28±3·28)mg·h·L-1,AUC0~∞为(29·43±3·54)mg·h·L-1。结论:CFPZ片体内过程符合血管外二室模型,口服后吸收迅速。本方法准确、灵敏、简便、特异性强、重现性好,适合于临床药动学研究。 OBJECTIVE: To establish an HPLC method for the determination of the plasma concentration of cefprozil (CFPZ) and the study of pharmacokinetics of CFPZ. METHODS: A total of 10 healthy male volunteers received a single oral dose of 500 mg tablets of cefprozil on empty stomach. The plasma concentration of cefprozil was determined by HPLC; in which the chromatographic column was Kromasil KR100- 5C18, and the mobile phase was 0.01mol·L^-1KH2PO4 aq. sol. - acetonitrile (100 : 9.5) at a flow rate of 1.0 mL·min^-1; the detective wavelength was 254 nm; the column temperature was room temperature and the sample size was 20μL. RESULTS: The calibration curves of CFPZ were linear in the range of 0.25-15 μg·mL^-1 (r=0. 999 9) with a quantitation limit of 0.25 μg·mL^-1. The intra- day RSD of CFPZ (0.25, 0.5, 2.5 μg·mL^-1) were 4.8%, 3.5% and 1.3%, respectively; and the inter-day RSD were 12.6%, 6.7% and 1.6%, respectively. The relative recoveries were 97.7%, 102.5% and 103.6%, respectively; and the absolute recoveries were 88.5%, 87.8% and 85.3%, respectively. The pharmacokinetic parameters of 500 mg of CFPZ tablets were as follows: Cmax was (8.66±1.57)mg·L^-1; tmax was (1.85±0.8)h; t1/2 was (1.4±0.18)h; AUC0-10 was (28.28±3.28)mg·h·L^-1 and AUC0-∞ was (29.43±3.54)mg·h·L^-1. CONCLUSION: The physiological disposition of Cefprozil fitted two compartment model and it can be rapidly absorbed after oral administration. The method is sensitive, simple, specific and reproducible, and can be applied to the pharmacokinetic study.
出处 《中国药房》 CAS CSCD 北大核心 2008年第8期592-594,共3页 China Pharmacy
关键词 头孢丙烯 高效液相色谱法 药动学 Cefprozil HPLC Pbarmacokinetics
  • 相关文献

参考文献5

二级参考文献12

  • 1王建平,辛洪涛,郑秀兰.头孢克洛治疗呼吸道感染的临床试验[J].新药与临床,1994,13(5):267-269. 被引量:7
  • 2何平,马宗生.希刻劳治疗呼吸道细菌性感染102例临床观察[J].中国实用内科杂志,1996,16(8):474-474. 被引量:2
  • 3戴自英 刘裕昆 汪复.实用抗菌药物学[M](第2版)[M].上海:上海科学技术出版社,1997.153-160.
  • 4Bonnet JP, Ginsberg D, Nolen TM,et al.Cefprozil vs.cefuroxime axetil in mild to moderate lower respiratory tract infections: A focus on bronchitis[J].Infect Med,1992, 9(Suppl E):48.
  • 5Fung Tomc JC, Huczko E, Stickle T,et al.Antibacterial activities of cefprozil compared with those of 13 oral cephems and 3 macrolides[J].Antimicrob Agents Chemother,1995,39:533.
  • 6Thornsberry C.Review of the in vitro antibacterial activity of cefprozil, a new oral antibiotic [J].Clin Infect Dis,1992,14(Suppl 2):189.
  • 7Barriere SL.Pharmacology and pharmacokinetics of cefprozil[J].Clin Infect Dis,1992, 14(Suppl 2):184.
  • 8Barbhaiya RH,Shukla VA,Gleason CR,et al.Comparison of cefprozil and cefaclor pharmacokinetics and tissue penetration[J].Antimicrob Agents Chemother,1990,34:1204.
  • 9Sappington RF,Fogarty C,Nolen TM,et al.A multicenter study of cefprozil vs clarithromycin in the treatment of acute bacterial exacerbations of chronic bronchitis[J].Infect Med,1997,14(Suppl A):61.
  • 10Barriere SL. Review of in vitro activity,pharmacokinetic characteristics, safety and clinical efficacy of cefproil, a new oral cephalosporin[J]. Ann Pharmacother, 1993, 27(9): 1082-1089.

共引文献30

同被引文献16

引证文献5

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部